Covered recipient · General Payments record
ROHIT AGGARWAL
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$633,290.92
- Reported across 286 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $90,459.50 | 21 |
| Honoraria | $22,375.00 | 3 |
| Travel and Lodging | $15,866.11 | 8 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,858.23 | 1 |
| Food and Beverage | $1,255.03 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Research & Development, LLC | $30,665.47 | 7 |
| PFIZER INC. | $26,750.00 | 3 |
| Octapharma USA, Inc. | $24,251.95 | 8 |
| Celgene Corporation | $12,847.87 | 2 |
| E.R. Squibb & Sons, L.L.C. | $9,533.82 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $8,598.26 | 5 |
| Alexion Pharmaceuticals, Inc. | $7,204.50 | 4 |
| UCB SA | $3,420.00 | 1 |
| AstraZeneca UK Limited | $2,148.00 | 1 |
| CSL Behring | $2,000.00 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,895.61 | 2 |
| Eli Lilly and Company | $800.00 | 1 |
| Boehringer Ingelheim International GmbH | $720.86 | 6 |
| BeiGene, Ltd. | $620.00 | 1 |
| ARGENX US, INC. | $217.00 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $87.45 | 1 |
| SOBI, INC | $28.62 | 1 |
| GlaxoSmithKline, LLC. | $24.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (51)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.